neamine has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, S; Hu, G; Liu, Y; Wu, Y; Zhang, X | 1 |
| Pan, PT; Wang, L; Wang, YC; Yang, LY; Yu, DH; Zhao, J | 1 |
2 other study(ies) available for neamine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Area Under Curve; Biological Availability; Cell Proliferation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Framycetin; Half-Life; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Ribonuclease, Pancreatic; Tissue Array Analysis; Up-Regulation; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Neamine inhibits cell proliferation, migration, and invasion in H7402 human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Framycetin; Humans; Liver Neoplasms; Neoplasm Invasiveness | 2010 |